Delivery systems

Abstract

Disclosed herein are delivery systems including coated and uncoated yarns, yarn precursors, threads, fibers, and other substrates for the constant or near-constant release of active compounds, as well as methods for manufacturing such delivery systems. The yarns, yarn precursors, threads, fibers, and other substrates can include a cross-linked hydrophobic elastomer and an active compound. One or more coatings that are impermeable or substantially impermeable to the active compound may partially or fully occlude the yarn or substrate to control release rates of the active compound. The delivery systems may be used in a variety of applications, including the making of articles of clothing, textiles, and fabrics, and may be used in methods of treating various conditions and diseases.

The invention claimed is: 
     
         1 . An article of clothing comprising:
 at least one yarn;   a polymer matrix comprising:
 a polymer; and 
 a biologically therapeutic active compound dispersed in the polymer, wherein the at least one yarn is treated with the polymer matrix, thereby providing at least one treated yarn that releases the biologically therapeutic active compound from the polymer matrix; and 
   wherein the at least one treated yarn is in a woven or knitted configuration as the article of clothing that is washable and reusable as the article of clothing;   wherein the article of clothing is constructed and configured to conform to at least one part of a body of a mammal, wherein the article of clothing is constructed and configured to contact the skin of the mammal with the at least one treated yarn; and   wherein the biologically therapeutic active compound released by the at least one treated yarn is delivered to the skin of the mammal.   
     
     
         2 . The article of clothing of  claim 1 , wherein the biologically therapeutic active compound is present in an amount for therapeutically effective delivery of the biologically therapeutic active compound to at least the portion of skin of the mammal. 
     
     
         3 . The article of clothing of  claim 1 , wherein the biologically therapeutic active compound includes one or more compounds selected from methyl salicylate, ethyl salicylate, arnica oil, peppermint oil, menthol, lidocaine, benzocaine, capsaicin, nonivamide, niacinamide, cannabidiol, caffeine, and hydrocortisone. 
     
     
         4 . The article of clothing of  claim 1 , wherein the at least one treated yarn is intermittently, selectively, or partially coated along its longitudinal axis or its length. 
     
     
         5 . The article of clothing of  claim 1 , wherein the at least one treated yarn is completely coated along its longitudinal axis or its length. 
     
     
         6 . The article of clothing of  claim 1 , wherein the polymer matrix comprises a hydrophobic polymer. 
     
     
         7 . The article of clothing of  claim 1 , wherein the polymer matrix is cross-linked. 
     
     
         8 . The article of clothing of  claim 1 , wherein the polymer comprises a cross-linked hydrophobic polymer, and wherein the biologically therapeutic active compound is a crystalline, a semi-crystalline, or an amorphous solid. 
     
     
         9 . The article of clothing of  claim 1 , wherein the biologically therapeutic active compound is a medication for treating or alleviating the pathological effects or symptoms of a disease or condition. 
     
     
         10 . The article of clothing of  claim 1 , wherein the article of clothing loses less than 25 percent of the biologically therapeutic active compound present before washing. 
     
     
         11 . The article of clothing of  claim 1 , wherein the biologically therapeutic active compound is released from the polymer matrix when the article of clothing is worn in skin contact with the mammal, wherein the biologically therapeutic active compound is configured to penetrate the skin of the mammal or is configured to be delivered to tissue below the skin of the mammal. 
     
     
         12 . The article of clothing of  claim 1 , wherein the article of clothing continues to release the biologically therapeutic active compound after at least one wash. 
     
     
         13 . The article of clothing of  claim 1 , wherein the at least one yarn includes an air-covered yarn. 
     
     
         14 . The article of clothing of  claim 1 , wherein the polymer matrix exhibits negligible swelling or no swelling in water. 
     
     
         15 . The article of clothing of  claim 1 , wherein the at least one treated yarn is partially coated with a coating material that is impermeable to the biologically therapeutic active compound. 
     
     
         16 . An article of clothing comprising:
 at least one treated yarn;   wherein the at least one treated yarn is configured to release a biologically therapeutic active compound;   wherein the article of clothing is constructed and configured to conform to at least one part of a body of a mammal, wherein the article of clothing is constructed and configured to provide the skin of a mammal contact with the at least one treated yarn; and   wherein the biologically therapeutic active compound released by the at least one treated yarn is delivered to the skin of the mammal.   
     
     
         17 . The article of clothing of  claim 16 , wherein the biologically therapeutic active compound is present in an amount for therapeutically effective delivery of the biologically therapeutic active compound to at least the portion of skin of the mammal. 
     
     
         18 . The article of clothing of  claim 16 , wherein the biologically therapeutic active compound includes one or more compounds selected from methyl salicylate, ethyl salicylate, arnica oil, peppermint oil, menthol, lidocaine, benzocaine, capsaicin, nonivamide, niacinamide, cannabidiol, caffeine, and hydrocortisone. 
     
     
         19 . The article of clothing of  claim 16 , further comprising at least one additional yarn configured to release a second biologically therapeutic active compound. 
     
     
         20 . An article of clothing comprising:
 at least one treated yarn;   wherein the at least one treated yarn is configured to release a biologically therapeutic active compound;   wherein the at least one treated yarn is in a woven or knitted configuration as the article of clothing;   wherein the biologically therapeutic active compound includes one or more compounds selected from methyl salicylate, ethyl salicylate, arnica oil, peppermint oil, menthol, lidocaine, benzocaine, capsaicin, nonivamide, niacinamide, cannabidiol, caffeine, and hydrocortisone; and   wherein the biologically therapeutic active compound is released by the at least one treated yarn and delivered to a skin of a mammal.